UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017606
Receipt number R000020388
Scientific Title The association between glucose oscillationand calculated by ADRR and atherosclerosis in Japanese patients with diabetes
Date of disclosure of the study information 2015/06/01
Last modified on 2019/01/29 12:26:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The association between glucose oscillationand calculated by ADRR and atherosclerosis in Japanese patients with diabetes

Acronym

ADRR and atherosclerosis

Scientific Title

The association between glucose oscillationand calculated by ADRR and atherosclerosis in Japanese patients with diabetes

Scientific Title:Acronym

ADRR and atherosclerosis

Region

Japan


Condition

Condition

Diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To analyze the relationship between glucose oscillation calculated by ADRR and progression of atherosclerosis

Basic objectives2

Others

Basic objectives -Others

Patients' back ground contributing ADRR

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

ADRR
Cervical IMT

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

SMBG

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Japanes patients with diabetes

Key exclusion criteria

1. patients who cannot perform SMBG
2. patients with severe renal failure and liver dysfunction
3. depression, alcoholic
4. cancer
5. patients taking steroids or interferon

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshihiko Yanase

Organization

Fukuoka university, school of medicine

Division name

Endocrinology and Diabetes Mellitus

Zip code


Address

7-45-1 Nanakuma, Jonan-ku, Fukuoka city, Fukuoka, Japan

TEL

092-801-1011

Email

tyanase@fukuoka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takashi Nomiyama

Organization

Fukuoka university, school of medicine

Division name

Endocrinology and Diabetes Mellitus

Zip code


Address

7-45-1 Nanakuma, Jonan-ku, Fukuoka city, Fukuoka, Japan

TEL

092-801-1011

Homepage URL


Email

tnomiyama@fukuoka-u.ac.jp


Sponsor or person

Institute

Fukuoka university, school of medicine, division of endocrinology and diabetes mellitus

Institute

Department

Personal name



Funding Source

Organization

Fukuoka university, school of medicine, division of endocrinology and diabetes mellitus

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 05 Month 15 Day

Date of IRB


Anticipated trial start date

2017 Year 07 Month 01 Day

Last follow-up date

2018 Year 12 Month 31 Day

Date of closure to data entry

2018 Year 12 Month 31 Day

Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2015 Year 05 Month 18 Day

Last modified on

2019 Year 01 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020388


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name